Other Charges
Merck & Co. Other Charges increased by 68.1% to -$138.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 494.3%, from $35.00M to -$138.00M. Over 3 years (FY 2021 to FY 2025), Other Charges shows a downward trend with a -51.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase suggests unexpected non-operating costs or one-time financial hits, which can negatively impact net income.
Detailed definition
This metric captures non-operating financial expenses that do not fall under standard categories like interest or taxes....
Peer comparison
Often found in the non-operating section of the income statement; peers may label these as 'other expenses' or 'sundry charges'.
hon_other_chargesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $103.00M | $450.00M | $334.00M | -$708.00M | -$438.00M | -$429.00M | $0.00 | -$89.00M | -$172.00M | -$126.00M | -$78.00M | $33.00M | -$42.00M | $162.00M | $35.00M | $7.00M | $238.00M | -$432.00M | -$138.00M |
| QoQ Change | — | +336.9% | -25.8% | -312.0% | +38.1% | +2.1% | +100.0% | — | -93.3% | +26.7% | +38.1% | +142.3% | -227.3% | +485.7% | -78.4% | -80.0% | >999% | -281.5% | +68.1% |
| YoY Change | — | — | — | — | -525.2% | -195.3% | -100.0% | +87.4% | +60.7% | +70.6% | — | +137.1% | +75.6% | +228.6% | +6.1% | +116.7% | +46.9% | — | -494.3% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Pharmaceutical | -$14.00M | -$27.00M | $163.00M | -$49.00M | -$21.00M | -$60.00M | $295.00M | -$55.00M |
| Animal Health | $1.00M | $1.00M | -$2.00M | -$1.00M | $0.00 | -$1.00M | — | $0.00 |
| Total | -$42.00M | $162.00M | — | $35.00M | $7.00M | $238.00M | -$432.00M | -$138.00M |
Animal Health, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Other Charges at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s other charges?
- Merck & Co. (MRK) reported other charges of -$138.00M in Q1 2026.
- How has Merck & Co.'s other charges changed year-over-year?
- Merck & Co.'s other charges decreased by 494.3% year-over-year, from $35.00M to -$138.00M.
- What is the long-term trend for Merck & Co.'s other charges?
- Over 3 years (2021 to 2025), Merck & Co.'s other charges has grown at a -51.6% compound annual growth rate (CAGR), from $1.34B to -$152.00M.
- What does other charges mean?
- Miscellaneous non-operating financial expenses not classified elsewhere.